Schedule 13G ownership disclosure
Oramed Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 68403P203
Event date: 2018-07-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 960,000
- Percent of class
- 5.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000095
- Form type
- SC 13G
- Filer
- ORAMED PHARMACEUTICALS INC.
- CIK
- CIK 1176309
- Filed
- Jul 03, 2018
- Reporting period
- Jul 03, 2018
- Description
- Schedule 13G beneficial ownership